Pharmaceutical Executive
Pediatric drugs require investments in formulation, but the market opportunity is worth the cost.
Eugene McNally
Advertisement
Articles by Eugene McNally
Advertisement
Latest Updated Articles
The Growing Pediatrics MarketAugust 1st 2004
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
3
The New Healthy Aging Imperative and What It Means for Pharma
4
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
5